LPCN · Lipocine Inc
United States · RS rating 12 · As of 2026-11-03
| Price | 1.46 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 13 / 19 / 24 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 2 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +40.7% |
| Sales growth Q/Q | +899.7% |
| Distance from 52-week high | +87.0% |
| Market cap (USD) | $18.9M |